Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$1,272,000
-62.75%
Shares
Shares Volume: 16,000 Shares
Average Share Price: $79.5
INSIDER
SINGLETON J MATTHEW
Director
reported on Oct 25 2024
traded on Oct 25 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 9,500 |
PURCHASES/SALES 1Y | 0 / 5 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $917,982.97 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
PURCHASES/SALES 1Y | 0 / 20 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $3,823,069.28 |
COMPANY PREVIOUS TRADES |